Merck KGaA makes changes to executive board
Stefan Oschmann will become a member of the executive board and general partner of Merck KGaA following the departure of Elmar Schnee, who leaves the company for personal reasons.
Oschmann will be responsible for Merck Serono and Consumer Health Care divisions and personally assume the lead of the Merck Serono division on 1 January 2011.
Kai Beckmann will also become a member of the executive board and general partner of Merck KGaA from 1 April 2011. He will take the newly created executive board position of human resources.
Frank Stangenberg-Haverkamp, chairman of E Merck, thanked Schnee for his contributions to the firm’s success and wished him all the best for the future.
He said Oschmann was the ideal candidate to drive the internationalisation of Merck Serono and to advance the company’s pharmaceutical research and development.
Since 2009 Oschmann has been president of emerging markets for Merck & Co.
Stangen-Haverkamp said Beckmann proved his management skills in the IT business and when he was md in Singapore and Malaysia. Since 2007, he has pushed forward the modernisation and globalisation of Merck KGaA’s IT function in the role of chief technology officer.
Subscribe now to Manufacturing Chemist to get unrestricted online access to our exclusive content and receive our high quality magazine every month.
|Merck KGaA||company profile|